These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29174187)

  • 1. Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer.
    Kimmick GG; Li X; Fleming ST; Sabatino SA; Wilson JF; Lipscomb J; Cress R; Bergom C; Anderson RT; Wu XC;
    J Geriatr Oncol; 2018 May; 9(3):214-220. PubMed ID: 29174187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.
    Sabatino SA; Thompson TD; Wu XC; Fleming ST; Kimmick GG; Trentham-Dietz A; Cress R; Anderson RT
    Breast Cancer Res Treat; 2014 Jul; 146(1):199-209. PubMed ID: 24899083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
    Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
    J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
    Schonberg MA; Marcantonio ER; Li D; Silliman RA; Ngo L; McCarthy EP
    J Clin Oncol; 2010 Apr; 28(12):2038-45. PubMed ID: 20308658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer in octogenarian. Are we doing our best? A population-registry based study.
    Martinez-Ramos D; Simon-Monterde L; Queralt-Martin R; Suelves-Piqueres C; Menor-Duran P; Escrig-Sos J
    Breast; 2018 Apr; 38():81-85. PubMed ID: 29274475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients.
    Wollschläger D; Meng X; Wöckel A; Janni W; Kreienberg R; Blettner M; Schwentner L
    Breast J; 2018 Mar; 24(2):120-127. PubMed ID: 28685896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance).
    Klepin HD; Pitcher BN; Ballman KV; Kornblith AB; Hurria A; Winer EP; Hudis C; Cohen HJ; Muss HB; Kimmick GG
    J Oncol Pract; 2014 Sep; 10(5):e285-92. PubMed ID: 25074878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer.
    Land LH; Dalton SO; Jensen MB; Ewertz M
    Br J Cancer; 2012 Nov; 107(11):1901-7. PubMed ID: 23079577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer.
    Pinder MC; Duan Z; Goodwin JS; Hortobagyi GN; Giordano SH
    J Clin Oncol; 2007 Sep; 25(25):3808-15. PubMed ID: 17664460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer.
    Li S; Liu J; Virnig BA; Collins AJ
    Breast Cancer Res Treat; 2017 Feb; 161(3):515-524. PubMed ID: 27933451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
    Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
    J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?
    Yang H; Zhou L; Wang S; Cao Y; Tong F; Liu P; Zhou B; Cheng L; Liu M; Liu H; Xie F; Guo J; Wang S; Peng Y
    Medicine (Baltimore); 2018 Oct; 97(40):e12690. PubMed ID: 30290661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab-related cardiotoxicity among older patients with breast cancer.
    Chavez-MacGregor M; Zhang N; Buchholz TA; Zhang Y; Niu J; Elting L; Smith BD; Hortobagyi GN; Giordano SH
    J Clin Oncol; 2013 Nov; 31(33):4222-8. PubMed ID: 24127446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
    Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
    J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
    Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS
    J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the association between adjuvant chemotherapy and function-related adverse events among older patients with early stage breast cancer.
    Mariano C; Lund JL; Peacock Hinton S; Htoo P; Muss H; Reeder-Hayes KE
    J Geriatr Oncol; 2017 Jul; 8(4):242-248. PubMed ID: 28601373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.